About MedSafe Follow-Up
A post-discharge recovery-safety platform designed to reinforce medication understanding and identify patient-reported concerns after hospital discharge.
Our Mission
MedSafe Follow-Up was created to help healthcare organizations identify medication-understanding gaps, patient-reported barriers, and recovery concerns that may emerge after hospital discharge.
Patients frequently leave the hospital with new medications, adjusted therapies, complex instructions, and unanswered questions. Some problems do not become apparent until the patient returns home.
MedSafe Follow-Up provides a structured Recovery Passport workflow that reinforces medication education, assesses understanding, captures post-discharge concerns, and supports prioritized clinical follow-up.
The platform is designed for quality-improvement evaluation and to complement—not replace—existing discharge processes and clinician judgment.
Clinical Perspective
MedSafe Follow-Up was developed by Durade Zebari, PharmD, B.S., founder of MedIntel Health LLC and a practicing hospital clinical pharmacist with experience in inpatient medicine, emergency medicine, medication safety, and transitions-of-care workflows.
The platform was designed around recurring post-discharge challenges observed in clinical practice:
- Medication-understanding gaps
- Medication access and adherence barriers
- Limited discharge-counseling time
- Health-literacy variability
- Recovery and social-support barriers
- Difficulty identifying follow-up needs after discharge
The workflow is designed to complement existing hospital education, discharge, and quality-improvement processes rather than replace clinician judgment.
Intended Use
MedSafe Follow-Up is designed as a post-discharge educational reinforcement, concern-identification, and quality-improvement workflow. It operates within the following boundaries:
- Educational reinforcement only — the platform does not provide individualized medical advice
- Not emergency monitoring — it does not replace real-time clinical assessment
- Not diagnostic — it does not diagnose or independently interpret patient symptoms
- Not autonomous clinical decision-making — clinical follow-up and treatment decisions remain with licensed healthcare professionals
- Not a replacement for clinicians — it supports rather than substitutes for existing clinical workflows
- Hospital and prescriber discharge instructions always take priority over platform content
Platform Roadmap
Potential future development areas may include:
- Expanded medication-module coverage
- Additional clinical service-line workflows
- Broader healthcare-setting support
- Additional clinically reviewed languages
- Enhanced quality-improvement reporting
- Expanded outcome-measurement capabilities
- Advanced barrier and recovery-concern analytics